Lambrecht et al., 2015 - Google Patents
Synthesis of dimeric ADP-ribose and its structure with human poly (ADP-ribose) glycohydrolaseLambrecht et al., 2015
View HTML- Document ID
- 17446326606692050052
- Author
- Lambrecht M
- Brichacek M
- Barkauskaite E
- Ariza A
- Ahel I
- Hergenrother P
- Publication year
- Publication venue
- Journal of the American Chemical Society
External Links
Snippet
Poly (ADP-ribosyl) ation is a common post-translational modification that mediates a wide variety of cellular processes including DNA damage repair, chromatin regulation, transcription, and apoptosis. The difficulty associated with accessing poly (ADP …
- 102100005222 PARG 0 title abstract description 227
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lambrecht et al. | Synthesis of dimeric ADP-ribose and its structure with human poly (ADP-ribose) glycohydrolase | |
He et al. | High-affinity small-molecule inhibitors of the menin-mixed lineage leukemia (MLL) interaction closely mimic a natural protein–protein interaction | |
Lin et al. | Discovery of a novel 2, 6-disubstituted glucosamine series of potent and selective hexokinase 2 inhibitors | |
Leonidas et al. | Crystal structures of ribonuclease A complexes with 5 ‘-diphosphoadenosine 3 ‘-phosphate and 5 ‘-diphosphoadenosine 2 ‘-phosphate at 1.7 Å resolution | |
Kistemaker et al. | Stereoselective ribosylation of amino acids | |
Ellermann et al. | Novel class of potent and cellularly active inhibitors devalidates MTH1 as broad-spectrum cancer target | |
Liu et al. | Metabolically generated stable isotope-labeled deoxynucleoside code for tracing DNA N6-methyladenine in human cells | |
Yuan et al. | Investigation of binding of udp-gal f and udp-[3-f] gal f to udp-galactopyranose mutase by std-nmr spectroscopy, molecular dynamics, and corcema-st calculations | |
Palermo et al. | Molecular simulations highlight the role of metals in catalysis and inhibition of type II topoisomerase | |
Poduch et al. | Design of inhibitors of orotidine monophosphate decarboxylase using bioisosteric replacement and determination of inhibition kinetics | |
Yuan et al. | Exploring the mechanism of binding of UDP-galactopyranose to UDP-galactopyranose mutase by STD-NMR spectroscopy and molecular modeling | |
Kuznetsov et al. | Pre-steady-state kinetic study of substrate specificity of Escherichia coli formamidopyrimidine− DNA glycosylase | |
Michel et al. | Computational and experimental druggability assessment of human DNA glycosylases | |
Itoh et al. | Synthesis and analysis of substrate analogues for UDP-galactopyranose mutase: implication for an oxocarbenium ion intermediate in the catalytic mechanism | |
Shi et al. | Bisubstrate analogue inhibitors of 6-hydroxymethyl-7, 8-dihydropterin pyrophosphokinase: synthesis and biochemical and crystallographic studies | |
Leonidas et al. | Toward rational design of ribonuclease inhibitors: High-resolution crystal structure of a ribonuclease A complex with a potent 3 ‘, 5 ‘-pyrophosphate-linked dinucleotide inhibitor | |
Mansoorabadi et al. | Conformational activation of poly (ADP-ribose) polymerase-1 upon DNA binding revealed by small-angle X-ray scattering | |
Burgos et al. | Luciferase-based assay for adenosine: application to S-adenosyl-L-homocysteine hydrolase | |
Ji et al. | A chimeric ATP-linked nucleotide enables luminescence signaling of damage surveillance by MTH1, a cancer target | |
Bujalowski et al. | Kinetic mechanism of nucleotide cofactor binding to Escherichia coli replicative helicase DnaB protein. stopped-flow kinetic studies using fluorescent, ribose-, and base-modified nucleotide analogues | |
Zhang et al. | HIV-1 integrase inhibitor-inspired antibacterials targeting isoprenoid biosynthesis | |
Andersen et al. | In-vitro replication studies on O 2-methylthymidine and O 4-methylthymidine | |
Major et al. | Molecular recognition in purinergic receptors. 2. Diastereoselectivity of the h-P2Y1-receptor | |
Seley et al. | (+)-7-Deaza-5 ‘-noraristeromycin as an anti-trypanosomal agent | |
Zhan et al. | Resurrecting the condemned: Identification of n-benzoxaborole benzofuran GSK8175 as a clinical candidate with reduced metabolic liability |